HermanWHEastmanRC. The effects of treatment on the direct costs of diabetesDiabetes Care. 1998 Dec; 21Suppl 3: C19–24.
2.
American Diabetes Association. Position statement: tests of glycemia in diabetes. Diabetes Care. 2004; 27 (Suppl 1): 91–3.
3.
HarrisMI; National Health and Nutrition Examination Survey (NHANES III). Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001 Jun; 24 (6): 979–82.
4.
BlondeLGinsbergBHHornSHirschIBJamesBMulcahyKNettlesASmoutRWrightH. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2002 Jan; 25 (1): 245–6.
5.
FarmerAWadeAGoyderEYudkinPFrenchDCravenAHolmanRKinmonthALNeilA. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007 Jul 21; 335 (7611): 132.
6.
The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30; 329 (14): 977–86.
7.
The UKPDS Research Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998 Sep 12; 352 (9131): 837–53.
8.
MazzeRSShamoonHPasmantierRLucidoDMurphyJHartmannKKuykendallVLopatinW. Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med. 1984 Aug; 77 (2): 211–7.